What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

Testa, L

What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. [electronic resource] - QJM : monthly journal of the Association of Physicians Jun 2010 - 367-77 p. digital

Publication Type: Journal Article; Review; Systematic Review

1460-2393

10.1093/qjmed/hcq017 doi


Clopidogrel
Drug Evaluation, Preclinical
Hemorrhage--complications
Humans
Piperazines--antagonists & inhibitors
Platelet Aggregation Inhibitors--pharmacokinetics
Prasugrel Hydrochloride
Purinergic P2 Receptor Antagonists
Randomized Controlled Trials as Topic
Receptors, Purinergic P2--therapeutic use
Risk Factors
Thiophenes--antagonists & inhibitors
Ticlopidine--analogs & derivatives